ERASCA VENTURES
ERASCA VENTURES
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-22 | Affini-T Therapeutics | Erasca Ventures investment in Venture Round - Affini-T Therapeutics | 175 M USD |
More informations about "Erasca Ventures"
Erasca Ventures - Crunchbase Investor Profile & Investments
Mar 22, 2022 Erasca Ventures is a venture capital firm. Lists Featuring This Company. Edit Lists Featuring This Company Section. Greater San Diego Area Venture Capital Investors . 157 …See details»
People - Erasca
Jonathan is Chairman and CEO of Erasca, which he co-founded in July 2018 with a mission to erase cancer. He is a physician-turned-venturepreneur at City Hill and ARCH Venture who …See details»
Jonathan E. Lim - Chairman, CEO & Co-Founder at …
Jonathan is Chairman and CEO of Erasca, which he co-founded in July 2018 with a mission to erase cancer. He is a physician-turned-venturepreneur who, since 2003, has been a leader and founding investor of four other biotechnology …See details»
On a Journey to Erase Cancer - investors.erasca.com
Erasca Ventures, we made an equity investment into Affini-T Therapeutics, which is developing TCR T-cell therapies against KRAS G12V, KRAS G12D, and KRAS G12C. 1 Licensor Joyo …See details»
Erasca Ventures - Investments, Portfolio & Company Exits
Erasca Ventures has invested in Affini-T Therapeutics on Mar 22, 2022. This investment - Venture Round - Affini-T Therapeutics - was valued at . obfuscated. obfuscated. How many …See details»
Founder's Letter - Erasca
Erasca’s name is a portmanteau that incorporates these dual meanings. That night, I registered the erasca.com URL from my hotel room. ... funds and leads mission-driven for-profit and non …See details»
Erasca - Funding, Financials, Valuation & Investors
Erasca is a developer of oncology drugs intended to provide precision oncology options. ... How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... Colt Ventures . …See details»
Erasca Ventures investor portfolio, rounds & team | Dealroom.co
Erasca Ventures Venture capital Claimed. Overview. Portfolio (0) Notes. Recent News about Erasca Ventures Edit. Portfolio analysis ...See details»
Erasca Announces Key Leadership Team Appointments and …
Aug 22, 2019 Prior to joining Erasca, Dr. Chacko was a principal at Versant Ventures, where he held a dual investing/operating role, helping lead investment opportunities across multiple …See details»
Erasca - Company Profile - Tracxn
Nov 19, 2024 Erasca ranks 6th among 2355 active competitors. 847 of its competitors are funded while 543 have exited. Overall, Erasca and its competitors have raised over $79B in …See details»
Woodbridge Laser Ventures, PLLC · 7113 Elizabeth Dr, Mc
Woodbridge Laser Ventures, PLLC (Entity #11421584) is a business entity in Mc Lean registered with the Clerk's Information System (CIS) of Virginia State Corporation Commission (SCC). …See details»
Benefit Ventures Corporation · 1480 Rt. 9 North, Suite 203, …
BENEFIT VENTURES CORPORATION (DOS #4395580) is a Foreign Business Corporation in Woodbridge, New Jersey registered with the New York State Department of State (NYSDOS). …See details»
Erasca Raises $200 Million Series B Financing - Erasca
Apr 27, 2020 Erasca Raises $200 Million Series B Financing April 27, 2020. ... Existing investors City Hill Ventures, Colt Ventures and LifeSci Venture Partners also participated meaningfully in …See details»
Moose Caliber Ventures Inc. · 17 Torgan Trail Woodbridge ON L4H …
Moose Caliber Ventures Inc. is a federal corporation in Woodbridge incorporated with Corporations Canada, a division of Innovation, Science and Economic Development (ISED) …See details»
David Chacko - Chief Business Officer at Erasca | The Org
David is Chief Business Officer of Erasca, and has deep experience in strategy, finance, business development and operations. He was previously a Principal at Versant Ventures, where he …See details»
Careers - Erasca
Jonathan is Chairman and CEO of Erasca, which he co-founded in July 2018 with a mission to erase cancer. He is a physician-turned-venturepreneur at City Hill and ARCH Venture who …See details»
Erasca Raises $200M Series B Financing - VC News Daily
Apr 27, 2020 Erasca, a company whose mission is to erase cancer, today announced the completion of a $200 million Series B financing round co-led by ARCH Venture Partners and …See details»
Series B - Erasca - 2020-04-27 - Crunchbase Funding Round Profile
Apr 27, 2020 Erasca raised $200000000 on 2020-04-27 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …See details»
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small …
2 days ago First-line and second-line treatment approaches for NSCLC with actionable genomic alterations consist mostly of targeted treatment with tyrosine kinase inhibitors (TKIs). 2,4 …See details»
Pharmaceutical Jobs - PharmaOpportunities
22nd Century Technologies 4:59 NewCo, a 5AM Ventures Company 4as 61st street service corp A.W. Beattie Career Center A2 Biotherapeutics A2 Biotherapeutics, Inc. Aadi Bioscience Inc. …See details»